-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The chemical compound N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide methanesulfonate, also known as MK-8628, is a novel and promising molecule in the field of pharmaceuticals and drug discovery.
This compound has been shown to exhibit potent and selective activity against certain disease targets, making it a valuable tool for the development of new therapies.
One key aspect of the chemical industry is the identification and development of new active pharmaceutical ingredients (APIs), which are the molecules that have therapeutic effects and are used in drugs.
MK-8628 is an example of an upstream product in this process, as it is a molecule that has been synthesized and characterized as a potential API.
Downstream from MK-8628, the compound can be further processed and transformed into a variety of different products.
One such product is a salt form of the compound, such as the methanesulfonate salt.
This salt form has different physical and chemical properties than the parent compound, and it may have different pharmacokinetic and pharmacodynamic properties as well.
Salt forms of APIs are commonly used in the pharmaceutical industry because they can improve the stability, solubility, and bioavailability of the API.
Another product that can be derived from MK-8628 is a prodrug, which is a molecule that is converted to the active form of the drug in the body.
Prodrugs are often used to improve the pharmacokinetic and pharmacodynamic properties of APIs by modifying their chemical structure or properties.
For example, a prodrug of MK-8628 could be designed to have improved oral bioavailability, longer half-life, or targeted delivery to specific tissues or cells.
In addition to drugs, MK-8628 and its derivatives can also be used in various other applications in the chemical industry.
For example, the compound may be used as a building block or starting point for the synthesis of other molecules, such as intermediates or other APIs.
MK-8628 may also be used as a research tool or reagent in various laboratory settings, such as in the study of biochemical pathways or the development of new assays or diagnostic tests.
Overall, the compound MK-8628 and its derivatives represent an important and promising tool for the development of new therapies and products in the chemical industry.
The upstream and downstream products derived from this compound can be used in a variety of applications and can help to advance our understanding of the underlying biology and chemistry of disease and drug action.
With continued research and development, MK-8628 and its derivatives may ultimately lead to the discovery of new and effective treatments for a range of diseases.